FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
New criteria for diagnosing, staging Alzheimer’s stirs controversy
By
Kristen Fischer
Jul 01, 2024
The Alzheimer’s Association set out new criteria for diagnosing and staging Alzheimer’s based on recent advancements, especially biomarkers that can biologically detect the disease instead of relying...
Is Mom late on bills? Could be sign of dementia, report finds
By
Kristen Fischer
Jun 05, 2024
Older adults who fall behind on paying their bills may have early signs of dementia and be susceptible to further financial risks, according to a recent report.
Study spots brain clusters linked to subjective memory complaints
By
Kristen Fischer
May 23, 2024
People with subjective memory complaints include two subgroups, and being in the lower performance cluster increased the risk for cognitive impairment, according to a study published Thursday in Alzheimer’s...
Older adults who volunteered more often had better emotional well-being, were less likely to have Alzheimer’s disease and had lower risks for not being able to perform activities of daily living.
Report: During pandemic, Alzheimer’s discharges to home health, home rise, while those to nursing homes...
By
Kristen Fischer
Mar 29, 2024
A new study pinpoints how the COVID-19 pandemic affected the post-hospital discharge settings for people with Alzheimer’s disease and related dementias (ADRDs). Discharges to nursing homes fell, while...
Study: Having two copies of gene mutation linked to Alzheimer’s may cause onset
By
Kristen Fischer
May 07, 2024
A new study finds that possessing two copies of a specific gene mutation that’s common in Alzheimer’s disease may be the cause behind the disease in those people.
Failure to account for cognitive limitations threatens reliability of complaint process: researchers
By
Josh Henreckson
Feb 02, 2024
Regulators haven’t found a way to fully account for the ways Alzheimer’s disease and other dementias affect the nursing home complaint process, likely leaving some deficiencies unaddressed, a new study...
Initiative expands veteran participation in dementia research
By
Foster Stubbs
Feb 20, 2024
A National Institute on Aging (NIA) and Department of Veteran Affairs (VA) initiative helped to recruit more veterans for Alzheimer’s research. The program, INviting Veterans InTo Enrollment in Alzheimer’s...
Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...